Brain+ Unveils New Visual Identity and Website, Showcasing Ayla Dementia Care Platform's Scalable Solutions
ByAinvest
Friday, Oct 11, 2024 3:12 am ET1min read
MIND--
Brain+'s Ayla brand represents hope for improved dementia care, embodying the company's commitment to clinical effectiveness and emotional support. The platform's scalability sets it apart from existing solutions, enabling Brain+ to reach a larger audience and expand its offerings along the patient pathway.
The upcoming product release, Ayla – your Home Companion, scheduled for 2025, is a significant step towards achieving this goal [1]. Ayla is a proprietary software-based solution for highly scalable offerings of Cognitive Stimulation Therapy (CST), a clinically proven interventional therapy for people with dementia [1].
Brain+ is fully on track to release Ayla – your CST Assistant, its first product, as a medical device software on the UK market by the end of September 2024 [1]. The company's product roadmap for 2025 includes three new digital dementia products and services to further broaden its offerings and provide additional support to patients [1].
Devika Wood, Chief Commercial Officer of Brain+, shared her ambition for the company to become a household name for dementia management and treatment [1]. To support this goal, Brain+ is creating a compelling and powerful new brand for Ayla, which will be shared over the coming weeks.
References:
[1] Brain+ A/S. (2024, September 23). Brain+ unveils new products planned for 2025 with next step expansions of its dementia offerings towards building the world's first scalable dementia management platform. https://www.inderes.dk/en/releases/brain-as-brain-informs-of-three-product-releases-planned-for-2025-and-introduces-a-platform-renaming-as-part-of-its-uk-commercialization
Brain+ has introduced a new visual identity and website to promote its Ayla Dementia Care platform, aiming to revolutionize dementia care. The Ayla brand represents hope for improved dementia care, with a scalable platform to offer accessible, engaging, and effective support. The new branding reflects Brain+’s dedication to clinical effectiveness and emotional support, with an upcoming product release, Ayla – your Home Companion, slated for 2025.
In a groundbreaking move, Brain+, a leading player in dementia care solutions, has announced the introduction of a new visual identity and website for its Ayla Dementia Care platform. This innovative platform aims to revolutionize dementia care by offering accessible, engaging, and effective support to those affected by dementia [1].Brain+'s Ayla brand represents hope for improved dementia care, embodying the company's commitment to clinical effectiveness and emotional support. The platform's scalability sets it apart from existing solutions, enabling Brain+ to reach a larger audience and expand its offerings along the patient pathway.
The upcoming product release, Ayla – your Home Companion, scheduled for 2025, is a significant step towards achieving this goal [1]. Ayla is a proprietary software-based solution for highly scalable offerings of Cognitive Stimulation Therapy (CST), a clinically proven interventional therapy for people with dementia [1].
Brain+ is fully on track to release Ayla – your CST Assistant, its first product, as a medical device software on the UK market by the end of September 2024 [1]. The company's product roadmap for 2025 includes three new digital dementia products and services to further broaden its offerings and provide additional support to patients [1].
Devika Wood, Chief Commercial Officer of Brain+, shared her ambition for the company to become a household name for dementia management and treatment [1]. To support this goal, Brain+ is creating a compelling and powerful new brand for Ayla, which will be shared over the coming weeks.
References:
[1] Brain+ A/S. (2024, September 23). Brain+ unveils new products planned for 2025 with next step expansions of its dementia offerings towards building the world's first scalable dementia management platform. https://www.inderes.dk/en/releases/brain-as-brain-informs-of-three-product-releases-planned-for-2025-and-introduces-a-platform-renaming-as-part-of-its-uk-commercialization

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet